- AU$84.46m
- AU$166.52m
- ZAR28.95m
- 19
- 57
- 21
- 25
Annual income statement for Renergen, fiscal year end - February 29th, ZAR millions except per share, conversion factor applied.
2020 February 29th | 2021 February 28th | 2022 February 28th | 2023 February 28th | 2024 February 29th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.63 | 1.93 | 2.64 | 12.7 | 29 |
Cost of Revenue | |||||
Gross Profit | -0.667 | -0.917 | -0.775 | 4 | 10.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 69.9 | 48.7 | 41 | 48.2 | 164 |
Operating Profit | -67.3 | -46.8 | -38.4 | -35.5 | -135 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -67.3 | -50.8 | -42.3 | -36.4 | -147 |
Provision for Income Taxes | |||||
Net Income After Taxes | -52.6 | -42.6 | -33.8 | -26.7 | -110 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -52.6 | -42.6 | -33.8 | -26.7 | -110 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -52.6 | -42.6 | -33.8 | -26.7 | -110 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.468 | -0.367 | -0.277 | -0.198 | -0.751 |